ALA 3.45% 14.0¢ arovella therapeutics limited

New financial year = new SUDA, page-2

  1. 180 Posts.
    lightbulb Created with Sketch. 96


    Hey Livas,

    Would love to grab your thoughts on a few things as I agree... lots of potential news flow. Suda have never been able to get across the value of anything hence our low MC.

    1- PK study release. How positive can the market react only being a pk study and knowing we need another 2 mil to head into phase 1.

    2 - TGA. How positive will the market be knowing only small milestone payments and significant royalties years away?

    3 - concerning a raise and in general - Management have no skin in the game. Is this a big concern for you? Doesn’t matter to them how low we raise as long as we keep moving forward. Kills long termer though.

    Atm Suda’s biggest problem is there is no value reflected in the SP. This makes me question how positive the market will be on the back of updates that have no short term money value.

    Cheers
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
-0.005(3.45%)
Mkt cap ! $147.0M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $95.42K 662.9K

Buyers (Bids)

No. Vol. Price($)
6 168013 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 1440985 13
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.